Meriden Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 693 Broad St, Meriden, CT 06450 Phone: 203-440-9686 Fax: 203-440-9689 |
Dr. Cheryl Ann Miller, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 41 Cook Ave, Meriden, CT 06451 Phone: 203-630-1077 |
Dr. Ronald Maringola Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 197 W Main St, Meriden, CT 06451 Phone: 203-237-6325 Fax: 203-238-4757 |
Steven Dmitri O'donnell, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 693 Broad St, Meriden, CT 06450 Phone: 203-440-9686 |
Advanced Spinal Care Of Meriden Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 197 W Main St, Meriden, CT 06451 Phone: 203-237-6325 Fax: 203-238-4757 |
Dr. Steven Joseph O'donnell, DC Chiropractor - Sports Physician Medicare: Accepting Medicare Assignments Practice Location: 74 S Broad St, Meriden, CT 06450 Phone: 203-235-0171 Fax: 203-235-3310 |
News Archive
A study published online in this week's Science shows that SPC3649, a breakthrough microRNA-targeted therapy developed by Santaris Pharma A/S using its proprietary Locked Nucleic Acid (LNA) technology, holds promise as a novel treatment for patients infected with the Hepatitis C virus (HCV).
Since the ancient times, mankind has used plants to treat diseases. An example is the plant Artemisia annua, used for over 2,000 years in traditional Chinese medicine to treat intermittent fevers.
A study led by the University at Buffalo and Roswell Park Cancer Institute has identified beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients.
Morinda Bioactives (formerly Tahitian Noni International) recently announced the release of seven new Fit Body Composition Supplements, one of which is Fit Eye. Fit Eye provides an exclusive formulation of highly effective bioactives derived from the most potent sources, including research-recommended levels of lutein, to support optimal eye health.
Expression of the microtubule-binding protein Tau is not a reliable means of selecting breast cancer patients for adjuvant paclitaxel chemotherapy, according to research led by The University of Texas M. D. Anderson Cancer Center.
› Verified 3 days ago